Prostate cancer treatment by radical therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Prostate Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Epithelial Cells Seminal Vesicles Chromosomes, Human, Pair 8 Rectum Stromal Cells

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Transgenic Adenoviridae

Diseases36

Prostatic Neoplasms Erectile Dysfunction Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Adenocarcinoma Neoplasm Metastasis Breast Neoplasms Disease Progression Prostatic Intraepithelial Neoplasia Neoplasm Invasiveness Bone Neoplasms Genetic Predisposition to Disease Lung Neoplasms Neoplasm Recurrence, Local Carcinoma Ovarian Neoplasms Colonic Neoplasms Prostatic Neoplasms, Castration-Resistant Stomach Neoplasms Pancreatic Neoplasms Cell Transformation, Neoplastic Neovascularization, Pathologic Urinary Bladder Neoplasms Colorectal Neoplasms Prostatic Diseases Uterine Cervical Neoplasms Prostatitis Radiation Injuries Disease Models, Animal Lymphedema Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Rectal Neoplasms Fatigue Genital Neoplasms, Female

Chemicals and Drugs66

Prostate-Specific Antigen Free Radicals Receptors, Androgen Androgens Hydroxyl Radical Antineoplastic Agents Tumor Markers, Biological Free Radical Scavengers Antineoplastic Agents, Hormonal Tosyl Compounds Neoplasm Proteins Androgen Receptor Antagonists Anilides RNA, Messenger Dihydrotestosterone Finasteride RNA, Small Interfering Cancer Vaccines Anticarcinogenic Agents Metribolone Taxoids Antineoplastic Agents, Phytogenic Flutamide Glutamate Carboxypeptidase II PTEN Phosphohydrolase DNA, Neoplasm 5-alpha Reductase Inhibitors Antigens, Neoplasm Nitriles Antioxidants Tumor Suppressor Protein p53 Testosterone Congeners Proto-Oncogene Proteins c-akt Testosterone Androstenols Plant Extracts 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Enzyme Inhibitors MicroRNAs Azasteroids Receptor, erbB-2 Phenylthiohydantoin Transcription Factors RNA, Neoplasm Hydroxides Antibodies, Monoclonal Tumor Suppressor Proteins Racemases and Epimerases Paclitaxel Reactive Oxygen Species Receptors, Estrogen Leuprolide Cholestenone 5 alpha-Reductase DNA-Binding Proteins Estramustine Goserelin Proto-Oncogene Proteins c-bcl-2 Cisplatin Fluorouracil Glutathione S-Transferase pi Tamoxifen Proto-Oncogene Proteins Receptor, Epidermal Growth Factor Protein Kinase Inhibitors DNA Primers Picrates

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Prostatectomy Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiometry Brachytherapy Radiotherapy Dosage Treatment Outcome Questionnaires Orchiectomy Early Detection of Cancer Neoplasm Staging Neoplasm Grading Xenograft Model Antitumor Assays Prognosis Reverse Transcriptase Polymerase Chain Reaction Risk Factors Neoplasm Transplantation Radiotherapy Transplantation, Heterologous Digital Rectal Examination Follow-Up Studies Blotting, Western Survival Rate Immunohistochemistry Combined Modality Therapy Retrospective Studies Survival Analysis Gene Expression Profiling Prospective Studies Case-Control Studies Risk Molecular Targeted Therapy Risk Assessment Tumor Burden Antineoplastic Combined Chemotherapy Protocols Transurethral Resection of Prostate Biopsy Sensitivity and Specificity Disease-Free Survival Clinical Trials as Topic SEER Program Cohort Studies Odds Ratio Biopsy, Needle Transfection Incidence Drug Screening Assays, Antitumor Registries Multivariate Analysis Oligonucleotide Array Sequence Analysis Electron Spin Resonance Spectroscopy Predictive Value of Tests Chemotherapy, Adjuvant Models, Biological Kaplan-Meier Estimate Tissue Array Analysis Logistic Models Reproducibility of Results Radiotherapy, Conformal Castration Drug Delivery Systems Nomograms Polymerase Chain Reaction Genetic Therapy Immunotherapy Flow Cytometry Disease Models, Animal Gene Knockdown Techniques Mass Screening Immunoenzyme Techniques Individualized Medicine Radiotherapy, Adjuvant Confidence Intervals Mastectomy In Situ Hybridization, Fluorescence Proportional Hazards Models Palliative Care Real-Time Polymerase Chain Reaction Phytotherapy Radiotherapy, Image-Guided

Psychiatry and Psychology3

Erectile Dysfunction Decision Making Smoking

Phenomena and Processes45

Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Genetic Predisposition to Disease Drug Resistance, Neoplasm Signal Transduction Cell Survival Time Factors Cell Growth Processes Risk Down-Regulation Cell Division Sensitivity and Specificity Dose-Response Relationship, Drug Genotype Odds Ratio Cell Movement Transfection Cell Cycle Up-Regulation DNA Methylation Promoter Regions, Genetic Mutation RNA Interference Polymorphism, Genetic Gene Silencing Nomograms Gene Expression Base Sequence Genes, Tumor Suppressor Gene Fusion Phosphorylation Drug Synergism Chromosomes, Human, Pair 8 Radiation Tolerance Transcription, Genetic Diet Oxidation-Reduction Polymorphism, Single Nucleotide Genes, Neoplasm DNA Damage Alleles Tumor Microenvironment Phenotype Enzyme Activation

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Individualized Medicine

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science10

Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Questionnaires Survival Rate SEER Program Incidence Registries Radiotherapy, Conformal Base Sequence Molecular Sequence Data

Named Groups4

Survivors European Continental Ancestry Group African Americans African Continental Ancestry Group

Health Care35

Treatment Outcome Questionnaires Risk Factors Watchful Waiting Follow-Up Studies Survival Rate Retrospective Studies Survival Analysis Prospective Studies Case-Control Studies Risk Risk Assessment National Cancer Institute (U.S.)Sensitivity and Specificity Disease-Free Survival Clinical Trials as Topic SEER Program Cohort Studies Odds Ratio Incidence Age Factors Registries Multivariate Analysis Predictive Value of Tests Kaplan-Meier Estimate Logistic Models Reproducibility of Results Nomograms Radiation Injuries Mass Screening Confidence Intervals American Cancer Society Proportional Hazards Models Palliative Care Sperm Banks

Geographicals3

United States Japan Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Prostate Prostatectomy Prostate-Specific Antigen Radiotherapy, Intensity-Modulated Free Radicals Receptors, Androgen Radiotherapy Planning, Computer-Assisted Cell Line, Tumor Erectile Dysfunction Radiometry Brachytherapy Radiotherapy Dosage Decision Making Quality of Life Treatment Outcome Androgens Hydroxyl Radical Neoplasms Gene Expression Regulation, Neoplastic Questionnaires Prostatic Hyperplasia Antineoplastic Agents Neoplasms, Hormone-Dependent Orchiectomy Mice, Nude Adenocarcinoma Tumor Markers, Biological Early Detection of Cancer Neoplasm Metastasis Breast Neoplasms Disease Progression Free Radical Scavengers Neoplasm Staging Apoptosis Prostatic Intraepithelial Neoplasia Cell Proliferation Neoplasm Invasiveness Bone Neoplasms Neoplasm Grading Xenograft Model Antitumor Assays Antineoplastic Agents, Hormonal Tosyl Compounds Tumor Cells, Cultured Prognosis Neoplasm Proteins Reverse Transcriptase Polymerase Chain Reaction Risk Factors Androgen Receptor Antagonists Genetic Predisposition to Disease Lung Neoplasms Neoplasm Transplantation Drug Resistance, Neoplasm Anilides RNA, Messenger Neoplasm Recurrence, Local Radiotherapy Transplantation, Heterologous Signal Transduction Cell Survival Digital Rectal Examination Watchful Waiting Follow-Up Studies Blotting, Western Survival Rate Immunohistochemistry Combined Modality Therapy Carcinoma Retrospective Studies United States Medical Oncology Dihydrotestosterone Survival Analysis Gene Expression Profiling Prospective Studies Survivors Finasteride RNA, Small Interfering Ovarian Neoplasms Case-Control Studies Time Factors Colonic Neoplasms Cell Growth Processes Risk Molecular Targeted Therapy Cancer Vaccines Risk Assessment National Cancer Institute (U.S.)Tumor Burden Antineoplastic Combined Chemotherapy Protocols Transurethral Resection of Prostate Down-Regulation Anticarcinogenic Agents Biopsy Metribolone Cell Division Sensitivity and Specificity Taxoids Mice, SCID Antineoplastic Agents, Phytogenic

No FAQ available that match "prostate cancer treatment by radical therapy"